Medifast, Inc. Announces Second Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Medifast (MED) Tops Q2 EPS by 3c, Revenues Beat; Raises FY19 EPS/Revenue Guidance
August 1, 2019 5:51 PM EDTMedifast (NYSE: MED) reported Q2 EPS of $1.75, $0.03 better than the analyst estimate of $1.72. Revenue for the quarter came in at $187.1 million versus the consensus estimate of $182.26 million.
Record revenue up 59.5% to $187.1 millionNet income up 51.3% to $21.4 million55.3% growth in active earning OPTAVIA Coaches to 30,600Earnings per diluted share ("EPS") of $1.75, an increase of 50.9%"These record results are another demonstration of Medifast's continued commitment to delivering sustainable growth through our mission to offer the... More



